Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Hart

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scientific American|November 1, 2016
Our Senseless Pot LawsCarl Hart
Trends in Psychiatry and Psychotherapy|July 13, 2023
A comprehensive assessment of impulsivity requires more than a single questionnaireIsabella Fonseca, Carl Hart
Psychopharmacology|July 13, 2014
Drinking and the brain: careful selection of research participants requiredElizabeth Avegno, Carl Hart
Psychiatry and Clinical Neurosciences|November 26, 2010
Determining cognitive deterioration requires multiple tests administered on more than one occasionCarl Hart, A Caldwell Powell
Health Security|June 8, 2021
Access to Harm Reduction Treatment Among Formerly Incarcerated Individuals During the COVID-19 EraTawandra L Rowell-Cunsolo, Meghan Bellerose, Carl Hart
Addiction & Health|November 29, 2023
Inappropriate Conclusions Regarding Neurotoxicity in Methadone and Methamphetamine Users: Comment on "Investigating cognitive functions in methadone users in comparison with methadone and methamphetamine users and control group"Jacqueline A Erler, Carl Hart, Christopher Medina-Kirchner
Drug and Alcohol Dependence|September 15, 2005
Smoked cocaine discrimination in humans: effects of gabapentinMargaret Haney, Carl Hart, Eric D Collins, et al.
Lancet (London, England)|July 24, 2010
Amphetamine-group substances and HIVGrant Colfax, Glenn-Milo Santos, Priscilla Chu, et al.
Health & Justice|November 24, 2025
Examining predictors of substance use and treatment adequacy among formerly incarcerated individuals with a history of opioid and cocaine use: research protocolTawandra Rowell-Cunsolo, Meghan Bellerose, George Musa, et al.
Lancet (London, England)|March 30, 2016
Public health and international drug policyJoanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scientific American|November 1, 2016
Our Senseless Pot LawsCarl Hart
Trends in Psychiatry and Psychotherapy|July 13, 2023
A comprehensive assessment of impulsivity requires more than a single questionnaireIsabella Fonseca, Carl Hart
Psychopharmacology|July 13, 2014
Drinking and the brain: careful selection of research participants requiredElizabeth Avegno, Carl Hart
Psychiatry and Clinical Neurosciences|November 26, 2010
Determining cognitive deterioration requires multiple tests administered on more than one occasionCarl Hart, A Caldwell Powell
Health Security|June 8, 2021
Access to Harm Reduction Treatment Among Formerly Incarcerated Individuals During the COVID-19 EraTawandra L Rowell-Cunsolo, Meghan Bellerose, Carl Hart
Addiction & Health|November 29, 2023
Inappropriate Conclusions Regarding Neurotoxicity in Methadone and Methamphetamine Users: Comment on "Investigating cognitive functions in methadone users in comparison with methadone and methamphetamine users and control group"Jacqueline A Erler, Carl Hart, Christopher Medina-Kirchner
Drug and Alcohol Dependence|September 15, 2005
Smoked cocaine discrimination in humans: effects of gabapentinMargaret Haney, Carl Hart, Eric D Collins, et al.
Lancet (London, England)|July 24, 2010
Amphetamine-group substances and HIVGrant Colfax, Glenn-Milo Santos, Priscilla Chu, et al.
Health & Justice|November 24, 2025
Examining predictors of substance use and treatment adequacy among formerly incarcerated individuals with a history of opioid and cocaine use: research protocolTawandra Rowell-Cunsolo, Meghan Bellerose, George Musa, et al.
Lancet (London, England)|March 30, 2016
Public health and international drug policyJoanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, et al.
Pageof 1